Literature DB >> 15919084

RNA interference induced by siRNAs modified with 4'-thioribonucleosides in cultured mammalian cells.

Shuichi Hoshika1, Noriaki Minakawa, Hiroyuki Kamiya, Hideyoshi Harashima, Akira Matsuda.   

Abstract

Short interfering RNAs (siRNAs) variously modified with 4'-thioribonucleosides against the Photinus luciferase gene were tested for their induction of the RNA interference (RNAi) activity in cultured NIH/3T3 cells. Results indicated that modifications at the sense-strand were well tolerated for RNAi activity except for full modification with 4'-thioribonucleosides. However, the activity of siRNAs modified at the antisense-strand was dependent on the position and the number of modifications with 4'-thioribonucleosides. Since modifications of siRNAs with 4'-thioribonucleosides were well tolerated in RNAi activity compared with that of 2'-O-methyl nucleosides, 4'-thioribonucleosides might be potentially useful in the development of novel and effective chemically modified siRNAs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15919084     DOI: 10.1016/j.febslet.2005.04.073

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

1.  Functional characterization of human osteoclast inhibitory peptide-1 (OIP-1/hSca) gene promoter.

Authors:  Shanmugarajan Srinivasan; Masahiro Ito; Hiroshi Kajiya; L Lyndon Key; Theresa L Johnson-Pais; Sakamuri V Reddy
Journal:  Gene       Date:  2005-12-27       Impact factor: 3.688

Review 2.  Chemical modification: the key to clinical application of RNA interference?

Authors:  David R Corey
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

3.  Effect of base modifications on structure, thermodynamic stability, and gene silencing activity of short interfering RNA.

Authors:  Katarzyna Sipa; Elzbieta Sochacka; Julia Kazmierczak-Baranska; Maria Maszewska; Magdalena Janicka; Genowefa Nowak; Barbara Nawrot
Journal:  RNA       Date:  2007-06-21       Impact factor: 4.942

4.  Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.

Authors:  Jesper B Bramsen; Jørgen Kjems
Journal:  Front Genet       Date:  2012-08-20       Impact factor: 4.599

5.  Intracellular stability of 2'-OMe-4'-thioribonucleoside modified siRNA leads to long-term RNAi effect.

Authors:  Mayumi Takahashi; Chisato Nagai; Hiroto Hatakeyama; Noriaki Minakawa; Hideyoshi Harashima; Akira Matsuda
Journal:  Nucleic Acids Res       Date:  2012-03-12       Impact factor: 16.971

6.  Targeted delivery of siRNA.

Authors:  Sabrina Oliveira; Gert Storm; Raymond M Schiffelers
Journal:  J Biomed Biotechnol       Date:  2006

7.  Synthesis and properties of 4'-ThioDNA: unexpected RNA-like behavior of 4'-ThioDNA.

Authors:  Naonori Inoue; Noriaki Minakawa; Akira Matsuda
Journal:  Nucleic Acids Res       Date:  2006-07-19       Impact factor: 16.971

8.  Synthesis and characterization of 2'-modified-4'-thioRNA: a comprehensive comparison of nuclease stability.

Authors:  Mayumi Takahashi; Noriaki Minakawa; Akira Matsuda
Journal:  Nucleic Acids Res       Date:  2009-01-16       Impact factor: 16.971

9.  Improvements in siRNA properties mediated by 2'-deoxy-2'-fluoro-beta-D-arabinonucleic acid (FANA).

Authors:  Thomas Dowler; Denis Bergeron; Anna-Lisa Tedeschi; Luc Paquet; Nicolay Ferrari; Masad J Damha
Journal:  Nucleic Acids Res       Date:  2006-03-22       Impact factor: 16.971

10.  2'-fluoro-4'-thioarabino-modified oligonucleotides: conformational switches linked to siRNA activity.

Authors:  Jonathan K Watts; Niloufar Choubdar; Kashinath Sadalapure; Francis Robert; Alexander S Wahba; Jerry Pelletier; B Mario Pinto; Masad J Damha
Journal:  Nucleic Acids Res       Date:  2007-02-06       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.